Literature DB >> 15102803

Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55.

Li Fang1, Bogdan J Nowicki, Petri Urvil, Pawel Goluszko, Stella Nowicki, Steven L Young, Chandrasekhar Yallampalli.   

Abstract

We previously reported that inhibition of nitric oxide (NO) increases the rate of bacteremia and maternal mortality in pregnant rats with uterine infection by Escherichia coli expressing the Dr fimbria (Dr(+)). Epithelial binding and invasion by Dr(+) E. coli has also been shown to be dependent upon the expression level of the cellular receptor decay-accelerating factor (DAF; CD55). Here, we hypothesize that NO-related severity of infection could be mediated by changes in DAF expression and in the rate of epithelial invasion. The cellular basis of NO effects on epithelial invasion with Dr(+) E. coli was studied using Ishikawa endometrial carcinoma cells as an in vitro model of the human endometrial epithelium. Initially, we show that Ishikawa cells produce NO and express both NO synthase enzymes, NOS II and NOS III, and DAF protein. We next tested the abilities of both Dr(+) E. coli and a Dr(-) E. coli mutant to invade Ishikawa cells, and invasion was seen only with Dr(+) E. coli. Invasion by Dr(+) E. coli was decreased by elevated NO production and increased by NO inhibition. Elevated NO production significantly decreased DAF protein and mRNA expression in Ishikawa cells in a time- and dose-dependent manner. Here, we propose that in vitro invasion of an epithelial cell line is directly related to NO-regulated expression of DAF. The significance of NO-regulated receptor-ligand invasion is that it may represent a novel unrecognized phenomenon of epithelial defense against infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102803      PMCID: PMC387867          DOI: 10.1128/IAI.72.5.2907-2914.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness.

Authors:  B Nowicki; R Selvarangan; S Nowicki
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

Review 2.  Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.

Authors:  D Hourcade; M K Liszewski; M Krych-Goldberg; J P Atkinson
Journal:  Immunopharmacology       Date:  2000-08

3.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 4.  Role and regulation of nitric oxide in the uterus during pregnancy and parturition.

Authors:  C Yallampalli; Y L Dong; P R Gangula; L Fang
Journal:  J Soc Gynecol Investig       Date:  1998 Mar-Apr

5.  A critical role for murine complement regulator crry in fetomaternal tolerance.

Authors:  C Xu; D Mao; V M Holers; B Palanca; A M Cheng; H Molina
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

6.  Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin.

Authors:  A Hart; B J Nowicki; B Reisner; E Pawelczyk; P Goluszko; P Urvil; G Anderson; S Nowicki
Journal:  J Infect Dis       Date:  2001-04-06       Impact factor: 5.226

7.  Dual roles of amniotic fluid nitric oxide and prostaglandin E2 in preterm labor with intra-amniotic infection.

Authors:  C D Hsu; E Meaddough; K Aversa; S F Hong; I S Lee; R O Bahodo-Singh; L C Lu; J A Copel
Journal:  Am J Perinatol       Date:  1998       Impact factor: 1.862

8.  Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli.

Authors:  R Selvarangan; P Goluszko; V Popov; J Singhal; T Pham; D M Lublin; S Nowicki; B Nowicki
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

9.  Localized increase in nitric oxide production and the expression of nitric oxide synthase isoforms in rat uterus with experimental intrauterine infection.

Authors:  L Fang; B J Nowicki; Y L Dong; C Yallampalli
Journal:  Am J Obstet Gynecol       Date:  1999-09       Impact factor: 8.661

10.  Involvement of nitric oxide pathway in prostaglandin F2 alpha-induced preterm labor in rats.

Authors:  Y L Dong; B S Dai; P Singh; C Yallampalli
Journal:  Am J Obstet Gynecol       Date:  1997-10       Impact factor: 8.661

View more
  10 in total

Review 1.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

2.  Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats.

Authors:  Katarzyna Wroblewska-Seniuk; Stella Nowicki; Chantal Le Bouguénec; Bogdan Nowicki; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 3.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Preterm labor: CD55 in maternal blood leukocytes.

Authors:  Stella Nowicki; Michael G Izban; Edyta Pawelczyk; Vincent K Agboto; Siddarth Pratap; Gayle Olson; Bogdan Nowicki
Journal:  Am J Reprod Immunol       Date:  2009-05       Impact factor: 3.886

6.  PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor.

Authors:  Manu Banadakoppa; Pawel Goluszko; Daniel Liebenthal; Bogdan J Nowicki; Stella Nowicki; Chandra Yallampalli
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-05

7.  Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.

Authors:  Manu Banadakoppa; Daniel Liebenthal; David E Nowak; Petri Urvil; Uma Yallampalli; Gerald M Wilson; Aparna Kishor; Chandra Yallampalli
Journal:  FEBS J       Date:  2013-01-02       Impact factor: 5.542

8.  Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells.

Authors:  Manu Banadakoppa; Pawel Goluszko; Daniel Liebenthal; Chandra Yallampalli
Journal:  Cell Biol Int       Date:  2012-10-01       Impact factor: 3.612

9.  Nanodiamonds facilitate killing of intracellular uropathogenic E. coli in an in vitro model of urinary tract infection pathogenesis.

Authors:  Janaki Kannan Iyer; Alexia Dickey; Parvaneh Rouhani; Anil Kaul; Nirmal Govindaraju; Raj Narain Singh; Rashmi Kaul
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

10.  A shear stress micromodel of urinary tract infection by the Escherichia coli producing Dr adhesin.

Authors:  Beata Zalewska-Piątek; Marcin Olszewski; Tomasz Lipniacki; Sławomir Błoński; Miłosz Wieczór; Piotr Bruździak; Anna Skwarska; Bogdan Nowicki; Stella Nowicki; Rafał Piątek
Journal:  PLoS Pathog       Date:  2020-01-09       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.